A16 (B2) - TYPE 2 DIABETIC MELLITUS PATIENTS
Gender: Male and Female
Smoking habit: Smoker or non-smoker
Pot smoking
18 - 65
BMI : 30.0 - 39.9
Food restrictions : Fast
Clinic stay
- 30 Oct (07:00) to 30 Oct (13:00)
- 22 Jan (07:00) to 22 Jan (13:00)
Return visits
- 13 Nov (08:00)
- 27 Nov (08:00)
- 25 Dec (08:00)
- 5 Feb (08:00)
- 19 Feb (08:00)
- 16 Apr (08:00)
- 9 Jul (08:00)
- 1 Oct (08:00)
Participants must be available to stay at our clinic for all of the dates listed above and/or in the notes below. All clinic stays and return visits are mandatory. Times are subject to change.
Medication type
Help reduce an enzyme that breaks down certain sugars in the diet that can lead to fatty liver and diabetes.
Notes
We are looking for participants with Type 2 Diabetes Mellitus.
MULTIPLE STUDY DATES AVAILABLE.
Phase 1 study.
Administration mode: subcutaneous.
12 hours fasting before medical exam.
Participants must be fasted prior to dosing.
Blood volume: Male 440ml / Female 440ml (9 blood draws).
Your medical history and/or medication intake history may affect your participation on this study.
Please note that we are testing for drugs and alcohol during the medical evaluation.
This is preliminary information and changes could occur without notice